[[1]]
[1] "ICB_small_Hugo"

[[2]]
[1] "ICB_small_Liu"

[[3]]
[1] "ICB_small_Mariathasan"

[[4]]
[1] "ICB_small_Miao"

[[5]]
[1] "ICB_small_Nathanson"

[[6]]
[1] "ICB_small_Padron"

[[7]]
[1] "ICB_small_Riaz"

[[8]]
[1] "ICB_small_Van_Allen"

[1] "res_meta_percancer"
$Melanoma
$Melanoma$input_data
   Gene                          Study   N       Coef        SE         Pval
5 CXCL9    ICB_small_Nathanson, n = 24  24 -0.5400840 0.2552747 0.0343705233
8 CXCL9    ICB_small_Van_Allen, n = 42  42 -0.3980895 0.1813712 0.0281716349
3 CXCL9 ICB_small_Mariathasan, n = 195 195 -0.3473888 0.0832178 0.0000298703
6 CXCL9       ICB_small_Padron, n = 45  45 -0.1328303 0.1958716 0.4976768190
1 CXCL9         ICB_small_Hugo, n = 26  26  0.1597286 0.3090491 0.6052684705
  Cancer_type  Treatment
5    Melanoma      CTLA4
8    Melanoma      CTLA4
3    Melanoma PD-1/PD-L1
6    Melanoma   IO+combo
1    Melanoma PD-1/PD-L1

$Melanoma$meta_output
Number of studies: k = 5

                                         95%-CI     z  p-value
Random effects model -0.3191 [-0.4493; -0.1889] -4.80 < 0.0001

Quantifying heterogeneity:
 tau^2 < 0.0001 [0.0000; 0.5370]; tau = 0.0019 [0.0000; 0.7328]
 I^2 = 8.2% [0.0%; 80.9%]; H = 1.04 [1.00; 2.29]

Test of heterogeneity:
    Q d.f. p-value
 4.36    4  0.3595

Details on meta-analytical method:
- Inverse variance method
- Restricted maximum-likelihood estimator for tau^2
- Q-Profile method for confidence interval of tau^2 and tau

$Melanoma$meta_summery
  Cancer_type  Gene       Coef         SE   CI_lower   CI_upper        Pval
1    Melanoma CXCL9 -0.3191304 0.06643137 -0.4493334 -0.1889273 1.55596e-06
          I2    Q_Pval
1 0.08246284 0.3595341


$Other
$Other$input_data
   Gene                  Study  N        Coef        SE      Pval Cancer_type
7 CXCL9 ICB_small_Riaz, n = 23 23 -0.20447966 0.2926305 0.4846995       Other
2 CXCL9  ICB_small_Liu, n = 74 74 -0.09864513 0.1679199 0.5568992       Other
4 CXCL9 ICB_small_Miao, n = 33 33 -0.07729599 0.2187351 0.7238058       Other
   Treatment
7 PD-1/PD-L1
2 PD-1/PD-L1
4 PD-1/PD-L1

$Other$meta_output
Number of studies: k = 3

                                        95%-CI     z p-value
Random effects model -0.1103 [-0.3479; 0.1274] -0.91  0.3631

Quantifying heterogeneity:
 tau^2 = 0 [0.0000; 0.1125]; tau = 0 [0.0000; 0.3354]
 I^2 = 0.0% [0.0%; 89.6%]; H = 1.00 [1.00; 3.10]

Test of heterogeneity:
    Q d.f. p-value
 0.13    2  0.9365

Details on meta-analytical method:
- Inverse variance method
- Restricted maximum-likelihood estimator for tau^2
- Q-Profile method for confidence interval of tau^2 and tau

$Other$meta_summery
  Cancer_type  Gene      Coef        SE  CI_lower CI_upper      Pval I2
1       Other CXCL9 -0.110251 0.1212293 -0.347856 0.127354 0.3631169  0
     Q_Pval
1 0.9365225


[1] "list"
